Pathology and molecular genetics of meningioma

Abstract

Meningiomas are the most common intracranial primary neoplasm. Although most meningiomas are benign with a slow-growing behavior, some subtypes are associated with a high risk of recurrence and short survival times. Recent advances of technologies related to the clinical, histological, and molecular diversity of this common but heterogenous tumor are being reviewed.